AzTrials
AzTrials

Low Back PainNCT01699256

Enhanced Implementation of Low Back Pain Guidelines in General Practice

A study testing Guideline implementation as usual and Enhanced guideline implementation strategy in people with Low Back Pain, run by University of Aarhus at 1 site in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to evaluate whether an enhanced strategy of implementation of the new guideline will lower the number of patients getting referred to secondary care spine centres compared to a normal implementation strategy. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Low Back Pain
What is being tested?
Guideline implementation as usual and Enhanced guideline implementation strategy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,101 participants
Where
1 siteDenmark
Study dates
Oct 2012to May 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Provider number in the North Denmark Region (Practice level)
  • ICPC coded: L02, L03, L84, and L86 (Patient level)
  • Age 18-65 years (Patient level)

Who cannot join

  • No signed written consent form (Practice level)
  • Earlier participation in project testing (Practice level)
  • Already included (Patient level)
  • Patients with "red flags"/signs of serious pathology (Patient level)
  • Pregnancy (Patient level)
  • Insufficient Danish language skills (Patient level)

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Research Unit for General Practice in the North Denmark Region

    Aalborg, Aalborg, 9220

Other trials in Denmark

About this study

Official title: Enhanced Implementation of Low Back Pain Guidelines in General Practice: A Cluster Randomized Trial

The aim of this study is to evaluate whether an enhanced strategy of implementation of the new guideline will lower the number of patients getting referred to secondary care spine centres compared to a normal implementation strategy.

Read the detailed description

Introduction:

There is a need for more knowledge on how to introduce new guidelines effectively in general practice. A new low back pain treatment guideline is implemented in Denmark. This guideline demands that patients with low back pain who have not improved after eight weeks of primary care treatment should be referred to a secondary care spine centre.

Methods:

This is a cluster randomized trial. One hundred general practices define clusters and are randomly allocated to enhanced or usual implementation of the new guideline. The practices are all situated in the North Denmark Region and count two hundred general practitioners (GPs).

General practices in the control group will receive normal implementation of the new guideline, which include newsletters and briefings. In contrast the intervention group will receive an enhanced implementation strategy, adding visits from a consultant, two different stratification tools and feedback on guideline compliance. The two stratification tools: The STarT back screening tool (STarT) and a "Social and Occupational Screening" tool (SOS). The two screening tools subgroups patients and aids the clinicians in their choice of treatment.

Discussion:

To evaluate how change in behaviour may improve guideline adherence and patient treatment we plan two Ph.d. studies in relation to this study; one focusing on the clinical and an one on the economic aspects of the study. In addition a qualitative study is planned for patients refered to specialists in social medicine.

Conditions
Low Back Pain
Being tested
Guideline implementation as usual, Enhanced guideline implementation strategy
Keywords
General Practice, Low Back Pain, Guideline, Health Plan Implementation, Referral and Consultation
Medical subject headings
Low Back Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Guideline implementation as usualBehavioural

    Newsletters and Invitation to Meetings

  • Enhanced guideline implementation strategyBehavioural

    Enhanced guideline implementation strategy

Study groups in NCT01699256
Study groupRoleWhat they receive
Enhanced strategyExperimentalEnhanced implementation strategy
Receives: Behavioral: Enhanced guideline implementation strategy
Strategy as usualActive comparatorNormal implementation strategy
Receives: Behavioral: Guideline implementation as usual

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Referral of patients to a secondary care back centre

    Measured: 12 weeks

Secondary outcomes (6)
  1. Cost-effectiveness

    Measured: 4, 8, and 52 weeks

  2. Roland Morris 23q disability score

    Measured: 4, 8, and 52 weeks

  3. Numerical pain rating

    Measured: 4, 8, and 52 weeks

  4. EQ-5D (Life quality)

    Measured: 4, 8, and 52 weeks

  5. Sick-leave

    Measured: 4, 8, and 52 weeks

  6. Employment status

    Measured: 4, 8, and 52 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Oct 2012 (estimated)
  2. Study startOct 2012
  3. Primary completionMay 2016
  4. Study completionMay 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
1,101 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01699256
Sponsor's protocol ID
2008-58-0028
Status last verified
Jul 2015
First submitted
13 Sep 2012
Last updated
30 Nov 2016
Results posted
No
Data monitoring committee
No

Publications

  • Riis A, Rathleff MS, Jensen CE, Jensen MB. Predictive ability of the start back tool: an ancillary analysis of a low back pain trial from Danish general practice. BMC Musculoskelet Disord. 2017 Aug 23;18(1):360. doi: 10.1186/s12891-017-1727-6.

    PubMed 28835238
  • Riis A, Jensen CE, Bro F, Maindal HT, Petersen KD, Bendtsen MD, Jensen MB. A multifaceted implementation strategy versus passive implementation of low back pain guidelines in general practice: a cluster randomised controlled trial. Implement Sci. 2016 Oct 21;11(1):143. doi: 10.1186/s13012-016-0509-0.

    PubMed 27769263
  • Jensen CE, Riis A, Pedersen KM, Jensen MB, Petersen KD. Study protocol of an economic evaluation of an extended implementation strategy for the treatment of low back pain in general practice: a cluster randomised controlled trial. Implement Sci. 2014 Oct 8;9:140. doi: 10.1186/s13012-014-0140-x.

    PubMed 25293975
  • Riis A, Jensen CE, Bro F, Maindal HT, Petersen KD, Jensen MB. Enhanced implementation of low back pain guidelines in general practice: study protocol of a cluster randomised controlled trial. Implement Sci. 2013 Oct 20;8:124. doi: 10.1186/1748-5908-8-124.

    PubMed 24139140

Questions about this trial

What is this clinical trial studying?

A study testing Guideline implementation as usual and Enhanced guideline implementation strategy in people with Low Back Pain, run by University of Aarhus at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Nov 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Referral of patients to a secondary care back centre (time frame: 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01699256, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Nov 2016.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in